Nitazene Response Act

The Nitazene Response Act directs the Department of Health and Human Services to create and publish clinical guidelines for treating nitazene overdoses, a specific type of ultra-potent synthetic opioid. These guidelines will outline best practices for administering naloxone and provide instructions for emergency departments, hospitals, and rural emergency medical services. The Secretary must publish the guidelines online within 180 days of the bill's enactment and submit a report to Congress within one year detailing how the guidelines address nitazene overdose risks. The legislation defines nitazene to include various benzimidazole-opioids such as etonitazene and isotonitazene, ensuring the guidelines cover this growing class of substances.